Bologna’s Cellply secures €7.15 million to develop tools for faster immunotherapy and cell therapy development

Cellply, a Bologna-based DeepTech startup developing analytical tools enabling a deep characterisation of cancer immunotherapies, cell therapies and cell-based biotherapeutics, has completed the largest portion of its latest funding round, securing €7.15 million to date.  The investment was led by ENEA Tech e Biomedical, with additional participation from existing shareholders, including the SAFE conversion into […]

The post Bologna’s Cellply secures €7.15 million to develop tools for faster immunotherapy and cell therapy development appeared first on EU-Startups.